Jane Street Group LLC Invests $114,000 in Opthea Limited (NASDAQ:OPT)

Jane Street Group LLC bought a new stake in Opthea Limited (NASDAQ:OPT) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 26,632 shares of the company’s stock, valued at approximately $114,000.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group upgraded shares of Opthea to a “strong-buy” rating in a report on Tuesday, December 17th.

Opthea Price Performance

Shares of NASDAQ OPT opened at $3.82 on Wednesday. Opthea Limited has a 1-year low of $1.79 and a 1-year high of $5.45. The stock’s 50-day moving average is $3.59 and its 200 day moving average is $3.35.

About Opthea

Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.